Multiple Dose Safety and Efficacy of LKA651 in Patients With Diabetic Macular Edema
Clinical trial NCT03927690 · COMPLETED
Trial details
- NCT number
- NCT03927690
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-24
- Primary completion
- 2022-06-17
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.